Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Gain Therapeutics Initiates Multiple Ascending Dose Part Of Phase 1 Clinical Trial Of GT-02287 GCase-Targeting Small Molecule Therapy For GBA1 Parkinson's Disease

Author: Benzinga Newsdesk | February 27, 2024 03:03pm

Posted In: GANX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist